Marizyme, Inc. (MRZM)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jul 25, 2025
Marizyme Market Cap
Marizyme has a market cap or net worth of $132.00 as of September 17, 2025. Its market cap has decreased by -100.00% in one year.
Market Cap
132.00
Enterprise Value
26.59M
Revenue
183.42K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since May 3, 2010, Marizyme's market cap has decreased from 22.05M to 132.00, a decrease of -100.00%. That is a compound annual growth rate of -54.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 132.00 | -99.99% |
| Dec 30, 2024 | 1.08M | -76.87% |
| Dec 28, 2023 | 4.67M | -78.05% |
| Dec 30, 2022 | 21.28M | -70.17% |
| Dec 27, 2021 | 71.33M | -20.50% |
| Dec 31, 2020 | 89.72M | 768.82% |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 982.68M |
| Veradigm | 789.71M |
| Elite Pharmaceuticals | 750.21M |
| Tian'an Technology Group | 723.74M |
| Glass House Brands | 566.73M |
| Northwest Biotherapeutics | 390.10M |
| CytoDyn | 359.27M |
| American Oncology Network | 353.52M |